Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BC Medical Innovations Fund (BCMIF) is a venture capital fund based in Vancouver, British Columbia, that specializes in early-stage investments within the life sciences and healthcare sectors. Established as a labour-sponsored venture capital corporation (EVCC), the fund was designed to support the growth of the biomedical industry in British Columbia by providing equity financing to innovative companies. Historically managed by MDS Capital Corp (now Lumira Ventures) and later transferred to Impax Capital in 2005, BCMIF has invested in various biotech and medical device firms, including Inimex Pharmaceuticals and Adnavance Technologies. The fund's mission was to bridge the gap between academic research and commercial success, fostering a robust healthcare innovation ecosystem in the province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BC Medical Innovations Fund.